Philipp M. Meyer

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Hybrid Tau-PET/MRI study: Quantitative susceptibility mapping in progressive supranuclear palsy and its correlation with Tau-PET.

Hybrid Tau-PET/MRI study: Quantitative susceptibility mapping in progressive supranuclear palsy and its correlation with Tau-PET.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 01, 2025

Cholinergic network modulation in disinhibited eating behavior.

Cholinergic network modulation in disinhibited eating behavior.

Journal: Communications biology

Published: April 24, 2025

Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain.

Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 27, 2025

The relationship between α4β2-nicotinic acetylcholine receptor availability and brain arousal regulation as assessed by 2-[18F]F-A85380 PET and EEG following nicotine cessation in male individuals with nicotine dependence.

The relationship between α4β2-nicotinic acetylcholine receptor availability and brain arousal regulation as assessed by 2-[18F]F-A85380 PET and EEG following nicotine cessation in male individuals with nicotine dependence.

Journal: Psychiatry research. Neuroimaging

Published: January 13, 2025

Noradrenergic control of neurobehavior in human binge-eating disorder and obesity (NOBEAD): A smartphone-supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging.

Noradrenergic control of neurobehavior in human binge-eating disorder and obesity (NOBEAD): A smartphone-supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging.

Journal: The International journal of eating disorders

Published: December 02, 2022

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity.

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity.

Journal: Brain sciences

Published: October 25, 2022

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity.

Journal: Brain sciences

Published: July 25, 2022

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 23, 2022

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity.

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity.

Journal: Obesity surgery

Published: May 08, 2021

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study.

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 03, 2020

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 07, 2020

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study.

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study.

Journal: Translational psychiatry

Published: June 23, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026